Literature DB >> 23635958

Administration of isoflurane-controlled dyskinetic movements caused by anti-NMDAR encephalitis.

Christoph Gumbinger1, Christian Hametner, Brigitte Wildemann, Roland Veltkamp, Julian Bösel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23635958     DOI： 10.1212/WNL.0b013e318293e334

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  4 in total

Review 1.  [Intensive care aspects of autoimmune encephalitis].

Authors:  A Günther; J Schubert; O W Witte; D Brämer
Journal:  Med Klin Intensivmed Notfmed       Date:  2019-08-27       Impact factor: 0.840

2.  Management of Refractory Orofacial Dyskinesia Caused by Anti-N-methyl-d-aspartate Receptor Encephalitis Using Botulinum Toxin.

Authors:  Feixia Zheng; Xiuyun Ye; Xulai Shi; Neha Devi Poonit; Zhongdong Lin
Journal:  Front Neurol       Date:  2018-02-22       Impact factor: 4.003

3.  Anti-N-methyl-D-aspartate receptor encephalitis: A case report.

Authors:  Hua Li; Yan-Ke Guo; Ying-Lin Cui; Tao Peng
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

4.  Case report: Anti-NMDA receptor encephalitis manifesting as rapid weight loss and abnormal movement disorders with alternating unilateral ptosis and contralateral limb tremor.

Authors:  Yue Han; Sizhu Gong; Yafei Wan; Xiyao Fu; Enling He; Min Liu; Fang Deng
Journal:  Front Immunol       Date:  2022-09-15       Impact factor: 8.786
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.